Pacific Edge Limited

Ludwig Institute for Cancer Research Limited

Pacific Edge Biotechnology Limited

Michael Alan Black

Parry John Guilford

Jonathan Cebon

Thomas John

Robert Craig Pollock

Anthony Edmund Reeve

Bernhard Holzmann

Yu-Hsin Lin

Hjalmar Nekarda

Robert Rosenberg

Jan Friederichs

John Lindsay McCall

John Lindsay Mccall

Ahmad Anjomshoaa

Jan Friedrichs

This invention relates to prognostic signatures, and compositions and methods for determining the prognosis of cancer in a patient, particularly for colorectal cancer. Specifically, this invention relates to the use of genetic markers for the prediction of the prognosis of cancer, such as colorectal cancer based on signatures of genetic markers. In various aspects, the invention relates to a method of predicting the likelihood of long-term survival of a cancer patient, a method of determining a treatment regime for a cancer patient, a method of preparing a treatment modality for a cancer patient, among other methods as well as kits and devices for carrying out these methods.

Methods for treating colorectal cancer using prognostic genetic markers

This invention relates to prognostic signatures, and compositions and methods for determining the prognosis of cancer in a patient, particularly for colorectal cancer. Specifically, this invention relates to the use of genetic markers for the prediction of the prognosis of cancer, such as colorectal cancer, based on signatures of genetic markers. In various aspects, the invention relates to a method of predicting the likelihood of long-term survival of a cancer patient, a method of determining a treatment regime for a cancer patient, a method of preparing a treatment modality for a cancer patient, among other methods as well as kits and devices for carrying out these methods.

The invention relates to prognostic markers and prognostic signatures, and compositions and methods for determining the prognosis of cancer in a patient, particularly for melanoma. Specifically, the invention relates to the use of genetic and protein markers for the prediction of the risk of progression of a cancer, such as melanoma, based on markers and signatures of markers. In various aspects, the invention provides methods, compositions, kits, and devices based on prognostic cancer markers, specifically melanoma prognostic markers, to aid in the prognosis and treatment of cancer.

Methods for prognosis prediction for melanoma cancer

Devices and methods for prognosis prediction for melanoma cancer

Prognosis prediction for melanoma cancer

Growing community of inventors

Dunedin, New Zealand

Michael Alan Black